Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Trey Pham

Diagnostic Radiology Las Vegas, NV Medical Doctor

NPI 1659559334 CMS profile 257066

2020 Palomino Lane, # 100, Las Vegas, NV 89106

Open in the dashboard

General payments

$10,571

157 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Trey Pham of Las Vegas, NV is reported in the CMS Open Payments database as having received $10,571 across 157 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,126 15
2024 General $1,197 18
2023 General $1,313 17
2022 General $2,424 29
2021 General $2,046 29
2020 General $812 15
2019 General $1,652 34

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Trey Pham
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Trey Pham were reported at $1,126. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Trey Pham Diagnostic Radiology median Middle half National median
2019 $1,652 $108 $29–$318 $163
2020 $812 $65 $21–$252 $114
2021 $2,046 $92 $24–$292 $132
2022 $2,424 $104 $29–$294 $149
2023 $1,313 $110 $29–$337 $160
2024 $1,197 $113 $30–$356 $164
2025 $1,126 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Penumbra, Inc. $4,991 62 payments
  2. Inari Medical, Inc. $1,077 13 payments
  3. Medtronic, Inc. $1,031 15 payments
  4. W. L. Gore & Associates, Inc. $887 16 payments
  5. Sirtex Medical Inc $586 6 payments
  6. Stryker Corporation $517 5 payments
  7. Cook Medical LLC $311 17 payments
  8. Becton, Dickinson and Company $202 2 payments
  9. Viz.Ai, Inc. $147 1 payment
  10. Biocompatibles, Inc. $145 1 payment
  11. Other $678 19 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $10,571 157 payments
Products named General payments · program years 2019–2025
  1. Indigo System $1,724 18 payments
  2. CT THROMBECTOMY SYSTEM KIT $1,054 12 payments
  3. FLOWTRIEVER CATHETER, S $1,054 12 payments
  4. RED 72 $977 15 payments
  5. SIR-Spheres Microspheres $586 6 payments
  6. Penumbra Ruby Coil $452 5 payments
  7. Penumbra System $451 4 payments
  8. HawkOne $450 6 payments
  9. VIABAHN VBX Balloon Expandable Endoprosthesis $441 6 payments
  10. FLOWTRIEVER $330 3 payments
  11. Other $4,165 83 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 101 billing codes

Paid by Medicare

$78,990

Of which drugs: $677

Medicare patients

1,187

Average age 74

Services billed

8,200

618 women, 569 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 58%
Ischemic heart disease 52%
Diabetes 49%
Chronic kidney disease 46%
Heart failure 41%
Atrial fibrillation 36%
COPD 36%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 54 6,600 $677

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

157 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in Nevada

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record